ELISABETH DE VRIES, Groningen (The Netherlands)
ESMI Award Winner 2024
Talk Title: Molecular Imaging for the Bigger Cancer Medicine Picture
Professor of Medical Oncology at the University Medical Centre Groningen, The Netherlands
Prof. Elisabeth de Vries is recognised for her pioneering work in translating, from the laboratory to the clinic, novel radionuclide- and fluorescence-based imaging agents to detect cancer and its response to treatment.
She uses imaging in research that aims to increase the sensitivity of tumours to treatment, underlining the importance of imaging science for improving the outlook for cancer patients.
Elisabeth actively advocates a multidisciplinary approach with close interaction between all stakeholders and disciplines involved – from basic science to the clinic – including setting up robust clinical trials, which is crucial for improving diagnosis and treatment in oncology.
Elisabeth is an outstanding role model and leader who fully merits the highest award of the society for her innovative and game changing translational approach to advance and monitor treatment of cancer patients.
She received numerous awards and grants and is a member of the Royal Academy of Arts and Sciences (KNAW), Fellow of the European Academy of Cancer Sciences, and (co)-authored >840 publications (H-index: 137).
KULLERVO HYNYNEN, Toronto (Canada)
Talk Title: MRI-guided focused ultrasound for targeted drug delivery and gene therapy
Vice-President, Research and Innovation, Director focused ultrasound (FUS) group at Sunnybrook Research Institute in Toronto, Canada
Prof. Kullervo Hynynen’s research has focused on studying the effects of ultrasound beams on tissue and their utilization in therapy. He is investigating the use of focused ultrasound for noninvasive surgery, vascular surgery, targeted drug delivery and gene therapy.
He has developed theoretical models to help understand treatment parameters and to allow optimization of treatment devices. Kullervo has conducted in vivo experiments to investigate the various biological end points that can be induced by controlling the sonication parameters.
His research on ultrasound transducers has been used to design and develop new phased array applicators and better ways to deliver therapy. He is also looking at the use of magnetic resonance imaging to detect and quantify noninvasive ultrasound exposure in vivo.
Kullervo has developed several systems that are being tested clinically. He is currently exploring new ways to utilize ultrasound for imaging with the aim of using the methods for controlling delivery of therapy and aid in tumour diagnosis.
JOSEPH MORAN, Strasbourg (France)
Talk Title: The Metabolic Origin of Life
Director Laboratory of Chemical Catalysis at University of Strasbourg, France
Prof. Joseph Moran is professor at University of Strasbourg. He is a synthetic organic chemist interested in catalysis in complex systems and the origin of biological metabolism.
His research applies concepts from systems and supramolecular chemistry to catalysis and the chemical origins of life. His work has shed light on how metabolism may have arisen in prebiotic waters before the onset of Darwinian evolution.
He leads a young research group in Strasbourg that is applying systems and supramolecular ways of thinking to solve problems in catalysis and the chemical origins of life.
MICHELLE BRADBURY, New York (USA)
Talk Title: New Frontiers and Emerging Nanomaterials for Advancing Image-Guided Perioperative Cancer Care and Drug Delivery
Director, Molecular Imaging Institute & Perioperative Imaging & Engineered Technologies for Oncology at Cornell Institute for Engineering Innovations in Medicine in New York
Prof. Michelle Bradbury is Professor of Radiology and Endowed Professor of Imaging Research.
Michelle specializes in nanomedicine and molecular imaging / radiological sciences and led the successful clinical translation of C-Dots. She has amassed an impressive array of patents, publications, and research grants, in addition to receiving numerous recognitions. Michelle is an active leader in the nanotechnology community and has been named to several national and international nanomedicine boards.
STEPHEN BADYLAK, Pittsburgh (USA)
Talk Title: The Extracellular Matrix and Structure-Function Relationships in Regenerative Medicine
Professor in the Dep. of Surgery and the Dep. Bioengineering, Director of the Center for Pre-Clinical Tissue Engineering within the McGowan Institute
Prof. Stephen Badylak has been referred to as the “father of biologic scaffolds—particularly those composed of extracellular matrix (ECM). Since his early discoveries in the late 1980’s to the present day, he has challenged existing concepts of tissue repair and identified key physical and molecular signals that influence the host-wound healing response.
He was the first in the field of regenerative medicine to emphasize the importance and relevance of the immune system in both tissue/organ development and in the successful and functional outcomes that result from biomaterial approaches to tissue repair.
He is internationally recognized for his contributions and has successfully translated the use of such materials for treating unmet medical problems such as volumetric muscle loss and esophageal cancer.
- 10 Oct. 2023 | Opening Abstract Submission
- 21 Nov. 2023 | Deadline Abstract Submission
- 4 Jan. 2024 | Notification to Presenters
- 17 January | Early Registration Deadline
- 17 Jan. 2024 | Early Bird Registration Deadline